1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. California >
  6. Edge Biosystems Acquires Concise Separations

M&A Deal Summary

Edge Biosystems Acquires Concise Separations

On September 10, 2015, Edge Biosystems acquired life science company Concise Separations from Transgenomic

Acquisition Highlights
  • This is Edge Biosystems’ 1st transaction in the Life Science sector.
  • This is Edge Biosystems’ 1st transaction in the United States.
  • This is Edge Biosystems’ 1st transaction in California.

M&A Deal Summary
Date 2015-09-10
Target Concise Separations
Sector Life Science
Buyer(s) Edge Biosystems
Sellers(s) Transgenomic
Deal Type Divestiture

Target

Concise Separations

San Jose, California, United States
Concise Separations is a chemical analysis technique that separates and analyzes different substances according to their affinities for chemically stable, highly reactive, synthetic ion exchangers.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Edge Biosystems

Gaithersburg, Maryland, United States
Category Company
Founded 1990
Sector Life Science
DESCRIPTION

EdgeBio is an established research reagents and sequencing services company.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1

Seller(S) 1

SELLER

Transgenomic

Omaha, Nebraska, United States
Category Company
Founded 1997
Sector Life Science
Employees150
Revenue 27M USD (2014)
DESCRIPTION

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology, cardiology, neurology, and inherited diseases through advanced diagnostic technologies, products and services. Transgenomic also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2015 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-02 Transgenomic - Surveyor Kits Product Line

United States

Transgenomic - Surveyor Kits Product Line includes SURVEYOR mutation detection kits which provide researchers a method to detect mutations and polymorphisms in DNA from a variety of organisms.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-12 Precipio Diagnostics

New Haven, Connecticut, United States

Precipio Diagnostics has built a platform to harness the intellect, expertise and technology developed within academia, delivering quality diagnostic information to physicians and patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, and its experience delivering quality service, Precipio Diagnostics offers a new standard of diagnostic accuracy enabling the highest level of patient care.

Buy -
Mergr

Solution for

Product

Company

Legal